{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:16:31Z","timestamp":1792696591703,"version":"4.5.0"},"reference-count":134,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["KQTD20200909113758004"],"award-info":[{"award-number":["KQTD20200909113758004"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Until May 2022, zoonotic infectious disease monkeypox (MPX) caused by the monkeypox virus (MPXV) was one of the forgotten viruses considered to be geographically limited in African countries even though few cases outside of Africa were identified. Central and West African countries are known to be endemic for MPXV. However, since the number of human MPX cases has rapidly increased outside of Africa the global interest in this virus has markedly grown. The majority of infected people with MPXV have never been vaccinated against smallpox virus. Noteworthily, the MPXV spreads fast in men who have sex with men (MSM). Preventive measures against MPXV are essential to be taken, indeed, vaccination is the key. Due to the antigenic similarities, the smallpox vaccine is efficient against MPXV. Nevertheless, there is no specific MPXV vaccine until now. Nucleic acid vaccines deserve special attention since the emergency approval of two messenger RNA (mRNA)-based coronavirus disease 2019 (COVID-19) vaccines in 2020. This milestone in vaccinology has opened a new platform for developing more mRNA- or DNA-based vaccines. Certainly, this type of vaccine has a number of advantages including time- and cost-effectiveness over conventional vaccines. The platform of nucleic acid-based vaccines gives humankind a huge opportunity. Ultimately, there is a strong need for developing a universal vaccine against MPXV. This review will shed the light on the strategies for developing nucleic acid vaccines against MPXV in a timely manner. Consequently, developing nucleic acid-based vaccines may alleviate the global threat against MPXV.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1050309","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T04:52:16Z","timestamp":1666846336000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":43,"title":["Strategy of developing nucleic acid-based universal monkeypox vaccine candidates"],"prefix":"10.3389","volume":"13","author":[{"given":"Dimitri","family":"Papukashvili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nino","family":"Rcheulishvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjiao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng George","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/156.2.293","article-title":"Human monkeypox: Clinical features of 282 patients","volume":"156","author":"Jezek","year":"1987","journal-title":"J Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27884","article-title":"Monkeypox: A potential global threat","volume":"94","author":"Yang","year":"2022","journal-title":"J Med Virol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147866","article-title":"Monkeypox: A new threat","volume":"23","author":"Kmiec","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-022-01493-6","article-title":"Monkeypox outbreaks: 4 key questions researchers have","volume":"606","author":"Kozlov","year":"2022","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/22221751.2022.2095309","article-title":"Monkeypox virus emerges from the shadow of its more infamous cousin: Family biology matters","volume":"11","author":"Xiang","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.3390\/ani12172190","article-title":"Monkeypox: Some keys to understand this emerging disease","volume":"12","author":"Gomez-lucia","year":"2022","journal-title":"Animals"},{"key":"B7","article-title":"A human infection caused by monkeypox virus in basankusu territory, democratic republic of the Congo","volume":"46","author":"Ladnyj","year":"1972","journal-title":"Bull World Health Organ"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2018.00241","article-title":"Emergence of monkeypox as the most important orthopoxvirus infection in humans","volume":"6","author":"Sklenovsk\u00e1","year":"2018","journal-title":"Front Public Health"},{"key":"B9","unstructured":"Past U.S. cases and outbreaks2022"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.virs.2022.07.006","article-title":"Monkeypox virus: a re-emergent threat to humans","volume":"37","author":"Gong","year":"2022","journal-title":"Virol Sin"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7114a1","article-title":"Monkeypox in a traveler returning from Nigeria \u2014 Dallas, Texas, July 2021","volume":"71","author":"Rao","year":"2022","journal-title":"MMWR Morbid Mortal Weekly Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3201\/eid2805.220292","article-title":"Imported monkeypox from international traveler, Maryland, USA, 2021","volume":"28","author":"Costello","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3201\/eid2505.190076","article-title":"Diagnosis of imported monkeypox, Israel, 2018","volume":"25","author":"Erez","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2021.26.32.2100745","article-title":"Family cluster of three cases of monkeypox imported from Nigeria to the united kingdom, may 2021","volume":"26","author":"Hobson","year":"2021","journal-title":"Eurosurveillance"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3201\/eid2608.191387","article-title":"Imported monkeypox, Singapore","volume":"26","author":"Yong","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.38.1800509","article-title":"Two cases of monkeypox imported to the united kingdom, september 2018","volume":"23","author":"Vaughan","year":"2018","journal-title":"Eurosurveillance"},{"key":"B17","volume-title":"WHO director-general declares the ongoing monkeypox outbreak a public health emergency of international concern","year":"2022"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3201\/eid2002.130118","article-title":"Genomic variability of monkeypox virus among humans, democratic republic of the Congo","volume":"20","author":"Kugelman","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a010199","article-title":"Poxvirus DNA replication","volume":"5","author":"Moss","year":"2013","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries \u2014 April\u2013June 2022","volume":"387","author":"Thornhill","year":"2022","journal-title":"New Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.005108-0","article-title":"A prairie dog animal model of systemic orthopoxvirus disease using west African and Congo basin strains of monkeypox virus","volume":"90","author":"Hutson","year":"2009","journal-title":"J Gen Virol"},{"key":"B22","unstructured":"Monkeypox2022"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2022.102417","article-title":"Hospitalisation for monkeypox in Milan, Italy","volume":"49","author":"Moschese","year":"2022","journal-title":"Travel Med Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2022.102386","article-title":"New challenges in human monkeypox outside Africa: A review and case report from Italy","volume":"49","author":"Mileto","year":"2022","journal-title":"Travel Med Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11080924","article-title":"Monkeypox and its possible sexual transmission: Where are we now with its evidence","volume":"11","author":"Sah","year":"2022","journal-title":"Pathogens"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines-a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discovery"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9040390","article-title":"mRNA-based vaccines","volume":"9","author":"Kowalzik","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14051101","article-title":"Development of an LNP-encapsulated mRNA-RBD vaccine against SARS-CoV-2 and its variants","volume":"14","author":"Liu","year":"2022","journal-title":"Pharmaceutics"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2027906","article-title":"Safety and immunogenicity of two RNA-based covid-19 vaccine candidates","volume":"383","author":"Walsh","year":"2020","journal-title":"New Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00947-8","article-title":"Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data","volume":"397","author":"Haas","year":"2021","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2024671","article-title":"Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates","volume":"383","author":"Corbett","year":"2020","journal-title":"New Engl J Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00354","article-title":"Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants","volume":"4","author":"Flingai","year":"2013","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines1030225","article-title":"Vector design for improved DNA vaccine efficacy, safety and production","volume":"1","author":"Williams","year":"2013","journal-title":"Vaccines"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2110817118","article-title":"An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination","volume":"118","author":"Xia","year":"2021","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1987223","article-title":"DNA Vaccines for SARS-CoV-2: toward third-generation vaccination era","volume":"20","author":"Chavda","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/v14051049","article-title":"Development of DNA vaccine candidate against SARS-CoV-2","volume":"14","author":"Wang","year":"2022","journal-title":"Viruses"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/d41587-021-00023-5","article-title":"First COVID-19 DNA vaccine approved, others in hot pursuit","volume":"39","author":"Sheridan","year":"2021","journal-title":"Nat Biotechnol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"jiac298","DOI":"10.1093\/infdis\/jiac298","article-title":"Geographic structuring and divergence time frame of monkeypox virus in the endemic region","author":"Forni","year":"2022","journal-title":"J Infect Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e26531","DOI":"10.7759\/cureus.26531","article-title":"Monkeypox: A comprehensive review of transmission, pathogenesis, and manifestation","volume":"14","author":"Kaler","year":"2022","journal-title":"Cureus"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.10802","article-title":"Monkeypox in 2022 \u2014 what clinicians need to know","volume":"328","author":"Guarner","year":"2022","journal-title":"JAMA - J Am Med Assoc"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/v14091894","article-title":"Monkeypox, a literature review: What is new and where does this concerning virus come from","volume":"14","author":"Tiecco","year":"2022","journal-title":"Viruses"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01907-y","article-title":"Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus","volume":"28","author":"Isidro","year":"2022","journal-title":"Nat Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2022.102402","article-title":"Phylogenomic analysis of the monkeypox virus (MPXV) 2022 outbreak: Emergence of a novel viral lineage","volume":"49","author":"Luna","year":"2022","journal-title":"Travel Med Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1146\/annurev.immunol.21.120601.141049","article-title":"Poxviruses and immune evasion","volume":"21","author":"Seet","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/nm1457","article-title":"Quantification of antibody responses against multiple antigens of the two infectious forms of vaccinia virus provides a benchmark for smallpox vaccination","volume":"12","author":"P\u00fctz","year":"2006","journal-title":"Nat Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2004.08.015","article-title":"The exit of vaccinia virus from infected cells","volume":"106","author":"Smith","year":"2004","journal-title":"Virus Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1099","article-title":"Poxvirus tropism","volume":"3","author":"McFadden","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41577-022-00775-4","article-title":"Monkeypox: disease epidemiology, host immunity and clinical interventions","volume":"22","author":"Lum","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02302-06","article-title":"Vaccinia virus 4c (A26L) protein on intracellular mature virus binds to the extracellular cellular matrix laminin","volume":"81","author":"Chiu","year":"2007","journal-title":"J Virol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3390\/v4050688","article-title":"Poxvirus cell entry: How many proteins does it take","volume":"4","author":"Moss","year":"2012","journal-title":"Viruses"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2002.1446","article-title":"Analysis of the monkeypox virus genome","volume":"197","author":"Shchelkunov","year":"2002","journal-title":"Virology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.virol.2014.11.007","article-title":"RAB1A promotes vaccinia virus replication by facilitating the production of intracellular enveloped virions","volume":"475","author":"Pechenick","year":"2015","journal-title":"Virology"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)36019-8","article-title":"Purification and properties of the deoxyribonucleic acid polymerase induced by vaccinia virus","volume":"254","author":"Challberg","year":"1979","journal-title":"J Biol Chem"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus","volume":"83","author":"Smith","year":"2002","journal-title":"J of General Virol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.11.7.2497","article-title":"Entry of the two infectious forms of vaccinia virus at the plasma membane is signaling-dependent for the IMV but not the EEV","volume":"11","author":"Locker","year":"2000","journal-title":"Mol Biol Cell"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00228-6","article-title":"Clinical features and management of human monkeypox: a retrospective observational study in the UK","volume":"22","author":"Adler","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1086\/498155","article-title":"Reemergence of monkeypox: Prevalence, diagnostics, and countermeasures","volume":"41","author":"Nalca","year":"2005","journal-title":"Clin Infect Dis"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.220886","article-title":"A case of human monkeypox in Canada","volume":"194","author":"Sukhdeo","year":"2022","journal-title":"CMAJ: Can Med Assoc J = J l\u2019Association Medicale Can"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fitd.2022.951380","article-title":"The outbreak of human monkeypox in 2022: A changing epidemiology or an impending aftereffect of smallpox eradication","volume":"3","author":"Al-tammemi","year":"2022","journal-title":"Front Trop Dis"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18300","article-title":"Monkeypox virus case with maculopapular exanthem and proctitis during the Spanish outbreak in 2022","volume":"36","author":"Nicolas-Ruanes","year":"2022","journal-title":"Eur Acad Dermatol Venereol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e0005857","DOI":"10.1371\/journal.pntd.0005857","article-title":"Enhancing case definitions for surveillance of human monkeypox in the democratic republic of Congo","volume":"11","author":"Osadebe","year":"2017","journal-title":"PloS Negl Trop Dis"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e072410","DOI":"10.1136\/bmj-2022-072410","article-title":"Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series","volume":"378","author":"Patel","year":"2022","journal-title":"Br Med J"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-022-01896-7","article-title":"Monkeypox in-patients with severe anal pain","author":"Pf\u00e4fflin","year":"2022","journal-title":"Infection"},{"key":"B64","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40249-022-01007-6","article-title":"Monkeypox claims new victims: the outbreak in men who have sex with men","volume":"11","author":"Liu","year":"2022","journal-title":"Infect Dis Poverty"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1126\/science.add5966","article-title":"Why monkeypox is mostly hitting men who have sex with men","volume":"376","author":"Kupferschmidt","year":"2022","journal-title":"Science"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2022.102394","article-title":"Monkeypox virus: A novel sexually transmitted disease? a case report from France","volume":"49","author":"Vallee","year":"2022","journal-title":"Travel Med Infect Dis"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(22)00153-7","article-title":"Comment global human monkeypox outbreak: atypical presentation demanding urgent public health action","volume":"3","author":"Otu","year":"2022","journal-title":"Lancet Microbe"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1005769107","article-title":"Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the democratic republic of Congo","volume":"107","author":"Rimoin","year":"2010","journal-title":"Proc Natl Acad Sci (PNAS)"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.27.2200471","article-title":"Monkeypox outbreak predominantly affecting men who have sex with men, Madrid, Spain, 26 April to 16 June 2022","volume":"27","author":"Mart\u00ednez","year":"2022","journal-title":"Eurosurveillance"},{"key":"B70","unstructured":"Perceptions of monkeypox from those most at risk: men who have sex with men having multiple sexual partners2022"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e0010141","DOI":"10.1371\/journal.pntd.0010141","article-title":"The changing epidemiology of human monkeypox\u2013a potential threat? a systematic review","volume":"16","author":"Bunge","year":"2022","journal-title":"PloS Negl Trop Dis"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6710a5","article-title":"Emergence of monkeypox \u2014 West and central Africa, 1970\u20132017","volume":"67","author":"Durski","year":"2018","journal-title":"MMWR Morbid Mortal Weekly Rep"},{"key":"B73","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1600-065X.2008.00691.x","article-title":"Monkeypox virus and insights into its immunomodulatory proteins","volume":"225","author":"Weaver","year":"2009","journal-title":"Immunol Rev"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3201\/eid2704.203569","article-title":"Reemergence of human monkeypox and declining population immunity in the context of urbanization, Nigeria, 2017\u20132020","volume":"27","author":"Nguyen","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.81215-0","article-title":"A tale of two clades: monkeypox viruses","volume":"86","author":"Likos","year":"2005","journal-title":"J Gen Virol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2210125","article-title":"Tecovirimat and the treatment of monkeypox \u2014 past, present, and future considerations","volume":"387","author":"Sherwat","year":"2022","journal-title":"New Engl J Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac377","article-title":"Tecovirimat for the treatment of human monkeypox: An initial series from Massachusetts, united states","volume":"9","author":"Matias","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00927-20","article-title":"Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model","volume":"6","author":"Hutson","year":"2021","journal-title":"mSphere"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02173-10","article-title":"Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virus","volume":"85","author":"Smith","year":"2011","journal-title":"J Virol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(02)02091-6","article-title":"Cidofovir in the therapy and short-term prophylaxis of poxvirus infections","volume":"23","author":"De Clercq","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/v2122803","article-title":"Cidofovir activity against poxvirus infections","volume":"2","author":"Andrei","year":"2010","journal-title":"Viruses"},{"key":"B82","unstructured":"Treatment information for healthcare professionals2022"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-022-01742-y","article-title":"Prevention and treatment of monkeypox","volume":"82","author":"Rizk","year":"2022","journal-title":"Drugs"},{"key":"B84","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41598-018-37070-z","article-title":"Immunoinformatic and systems biology approaches to predict and validate peptide vaccines against Epstein\u2013Barr virus (EBV)","volume":"9","author":"Ali","year":"2019","journal-title":"Sci Rep"},{"key":"B85","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/000992287201100115","article-title":"Edward Jenner And the history of smallpox and vaccination","volume":"82","author":"Riedel","year":"1967","journal-title":"Bristol Medico Chirurgical J"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2034334","article-title":"On the shoulders of giants \u2014 from jenner\u2019s cowpox to mRNA covid vaccines","volume":"384","author":"Desmond","year":"2021","journal-title":"New Engl J Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2005.07.021","article-title":"The history of the smallpox vaccine","volume":"52","author":"Stewart","year":"2006","journal-title":"J Infect"},{"key":"B88","article-title":"Smallpox vaccine: Contraindications, administration, and adverse reactions","volume":"68","author":"Maurer","year":"2003","journal-title":"Am Family Physician"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.15167\/2421-4248\/jpmh2021.62.1.1631","article-title":"Louis Pasteur and Dom Pedro II engaged in rabies vaccine development","volume":"62","author":"Da","year":"2021","journal-title":"J Prev Med Hyg"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.633776","article-title":"A guide to nucleic acid vaccines in the prevention and treatment of infectious diseases and cancers: From basic principles to current applications","volume":"9","author":"Qin","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.628137","article-title":"The limitless future of RNA therapeutics","volume":"9","author":"Damase","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.16.6077","article-title":"Cationic liposome-mediated RNA transfection","volume":"86","author":"Malone","year":"1989","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Karik\u00f3","year":"2008","journal-title":"Am Soc Gene Ther"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.1c00197","article-title":"Modifications in an emergency: The role of N1- methylpseudouridine in COVID-19 vaccines","volume":"7","author":"Nance","year":"2021","journal-title":"ACS Cent Sci"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3390\/biologics1030020","article-title":"Nucleic acid vaccines for COVID-19: A paradigm shift in the vaccine development arena","volume":"1","author":"Chavda","year":"2021","journal-title":"Biologics"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines7020037","article-title":"A comparison of plasmid DNA and mRNA as vaccine technologies","volume":"7","author":"Liu","year":"2019","journal-title":"Vaccines"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113605","article-title":"DNA Vaccines\u2013how far from clinical use","volume":"19","author":"Hobernik","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B98","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.actbio.2018.08.033","article-title":"Engineering DNA vaccines against infectious diseases","volume":"15","author":"Lee","year":"2018","journal-title":"Acta Biomaterialia"},{"key":"B99","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1600-065X.2010.00980.x","article-title":"DNA Vaccines: an historical perspective and view to the future","volume":"239","author":"Liu","year":"2011","journal-title":"Immunol Rev"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118919","article-title":"DNA Vaccines against COVID-19: Perspectives and challenges","volume":"267","author":"Silveira","year":"2021","journal-title":"Life Sci"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.03.035","article-title":"Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses","volume":"25","author":"Bahl","year":"2017","journal-title":"Mol Ther"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.074","article-title":"mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials","volume":"37","author":"Feldman","year":"2019","journal-title":"Vaccine"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30294-4","article-title":"Outbreak of human monkeypox in Nigeria in 2017\u201318: a clinical and epidemiological report","volume":"19","author":"Yinka-ogunleye","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/17.3.643","article-title":"The transmission potential of monkeypox virus in human populations","volume":"17","author":"Fine","year":"1988","journal-title":"Int J Epidemiol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01096-0","article-title":"Investigating monkeypox","volume":"399","author":"Burki","year":"2022","journal-title":"Lancet (London England)"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.8.2919-2921.2002","article-title":"Outbreaks of disease suspected of being due to human monkeypox virus infection in the democratic republic of Congo in 2001","volume":"40","author":"Meyer","year":"2002","journal-title":"J Clin Microbiol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01487-8","article-title":"Evidence of human-to-dog transmission of monkeypox virus","volume":"400","author":"Seang","year":"2022","journal-title":"Lancet (London England)"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.37201\/req\/059.2022","article-title":"Monkeypox in humans: a new outbreak","volume":"6","author":"Javier","year":"2022","journal-title":"Off J Spanish Soc Chemother"},{"key":"B109","doi-asserted-by":"publisher","first-page":"e101163","DOI":"10.1371\/journal.pone.0101163","article-title":"Comparison and analysis of biological agent category lists based on biosafety and biodefense","volume":"9","author":"Tian","year":"2014","journal-title":"PloS One"},{"key":"B110","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/infdis\/jiq017","article-title":"Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge","volume":"203","author":"Hirao","year":"2011","journal-title":"J Infect Dis"},{"key":"B111","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1600-065X.2010.00975.x","article-title":"Smallpox vaccines: Targets of protective immunity","volume":"239","author":"Moss","year":"2011","journal-title":"Immunol Rev"},{"key":"B112","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using clustal omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol Syst Biol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1002\/pro.3290","article-title":"Clustal omega for making accurate alignments of many protein sequences","volume":"27","author":"Sievers","year":"2018","journal-title":"Protein Sci"},{"key":"B114","volume-title":"Multiple sequence alignments. bioinformatics","author":"Sievers","year":"2020"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1006","article-title":"The immune epitope database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.05.012","article-title":"mRNA delivery for therapeutic anti-HER2 antibody expression In vivo","volume":"27","author":"Rybakova","year":"2019","journal-title":"Mol Ther"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkl343","article-title":"AlgPred: Prediction of allergenic proteins and mapping of IgE epitopes","volume":"34","author":"Saha","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01784","article-title":"Contriving multi-epitope subunit of vaccine for COVID-19: Immunoinformatics approaches","volume":"11","author":"Dong","year":"2020","journal-title":"Front Immunol"},{"key":"B119","volume-title":"Lehninger principles of biochemistry","author":"Nelson","year":"2021"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btr335","article-title":"Immune system simulation online","volume":"27","author":"Rapin","year":"2011","journal-title":"Bioinformatics"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein-protein docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat Protoc"},{"key":"B122","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/prot.21117","article-title":"PIPER: An FFT-based protein docking program with pairwise potentials","volume":"65","author":"Kozakov","year":"2006","journal-title":"Proteins"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.09.032","article-title":"Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties","volume":"25","author":"Doytchinova","year":"2007","journal-title":"Vaccine"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinf"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp033","article-title":"Jalview version 2-a multiple sequence alignment editor and analysis workbench","volume":"25","author":"Waterhouse","year":"2009","journal-title":"Bioinformatics"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1385\/1-59259-890-0:571","article-title":"Protein identification and analysis tools on the ExPASy server; the proteomics protocols handbook","volume":"112","author":"Gasteiger","year":"2005","journal-title":"Humana Press"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty1018","article-title":"Commonly misunderstood parameters of NCBI BLAST and important considerations for users","volume":"35","author":"Gonz\u00e1lez-Pech","year":"2019","journal-title":"Bioinformatics"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj8754","article-title":"Accurate prediction of protein structures and interactions using a 3-track neural network","volume":"373","author":"Baek","year":"2021","journal-title":"Science"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2011.09.022","article-title":"Atomic-level protein structure refinement using fragment guided molecular dynamics conformation sampling","volume":"19","author":"Zhang","year":"2011","journal-title":"Structure"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt458","article-title":"GalaxyRefine: protein structure refinement driven by side-chain repacking","volume":"41","author":"Heo","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.11.017","article-title":"Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses","volume":"26","author":"Vogel","year":"2018","journal-title":"Mol Ther"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2020.08.003","article-title":"A new generation of vaccines based on alphavirus self-amplifying RNA","volume":"44","author":"Ballesteros-Briones","year":"2020","journal-title":"Curr Opin Virol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2018.00071","article-title":"Structural components for amplification of positive and negative strand VEEV splitzicons","volume":"5","author":"Blakney","year":"2018","journal-title":"Front Mol Biosci"},{"key":"B134","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.addr.2020.12.014","article-title":"Self-assembled mRNA vaccines","volume":"170","author":"Kim","year":"2021","journal-title":"Advanced Drug Delivery Rev"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1050309\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T04:52:23Z","timestamp":1666846343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1050309\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":134,"alternative-id":["10.3389\/fimmu.2022.1050309"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1050309","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]},"article-number":"1050309"}}